Biopharma industry experts gather in Singapore to discuss strategy, investment...

Biopharma industry experts gather in Singapore to discuss strategy, investment, innovation and partnerships

 

Singapore, 6 February 2012 – Come 19 - 22 March 2012, the annual BioPharma Asia Convention 2012 will take centre stage, providing a platform for the biopharma industry to find the right partners for their business needs at Marina Bay Sands, Singapore.

 

BioPharma Asia Convention 2012 is the region’s definitive strategic convention for the entire biopharmaceutical value chain, from partnering to drug discovery, manufacturing and clinical trials. Over 4000 biopharmaceutical professionals will convene to discuss the industry’s hottest issues, investment and partnership opportunities.

 

Partnering with Agency for Science, Technology and Research (A*STAR), Singapore Workforce Development Agency (WDA), Netherlands Foreign Investment Agency, Korea International Trade Association (KITA), and China Investment Promotion Agency (CIPA), BioPharma Asia Convention 2012 will be a diverse platform, opening up multiple levels of opportunities for the industry.

 

Hear directly from renowned speakers in the industry, across 6 conferences, 2 summits at BioPharma Asia Convention 2012. Alongside are presentations showcasing the latest technology and investment opportunities from various research institutes, biotech companies, and country associations. Coupled with more than 100 research posters on showcase and more than 60 on-floor seminars, BioPharma Asia Convention 2012 will provide all attendees various avenues of learning.

 

“I truly enjoyed the conference of BioPharma Asia Convention 2011 in Singapore. The diversity of topics and speakers are well distributed and at the same time, the topics and discussion are well focused by experts. Because of this conference, I could do immediate action for my business in Singapore and have meetings with several key stakeholders in the industry.” – Jin-San Yoo, President & CEO, PharmAbcine, Korea

 

Back for the fifth year, BioPharma Asia Convention 2012 will feature top distinguished and influential industry experts such as:

       •    Andreas Busch, Member of the Bayer HealthCare Executive Committee and Head of Global Drug Discovery, Bayer HealthCare, Germany 
       •    Anand Tharmaratham, Senior Vice President and Head of Asia Markets, Clinical Development, Quintiles, Singapore 
       •    Chihiro Yokota, Corporate Executive, Global Head of Business Development/Licensing & Alliances, Astellas Pharma, Japan 
       •    Saloman Azoulay, Senior Vice President, Medical and Development, Emerging Markets/Established Products Business Units, Pfizer, USA

 

To view the full list of speakers and conference agenda, visit www.terrapinn.com/biopharma .